Encephalitogenic peptide and platelet aggregation in multiple sclerosis
- 29 January 2009
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 73 (2), 141-144
- https://doi.org/10.1111/j.1600-0404.1986.tb03255.x
Abstract
Platelet aggregation (PA) stimulated by encephalitogenic peptide (EP) and PA induced by ADP were measured in 83 multiple sclerosis (MS) patients and 70 control subjects with other neurological diseases (OND). EP-stimulated PA was significantly increased in MS patients as compared with the controls. There was no significant difference in ADP-induced PA between patients with MS and OND. The results are discussed in terms of EP-stimulated platelets playing a role in the pathogenesis of MS by affecting the venular permeability of the brain.Keywords
This publication has 8 references indexed in Scilit:
- Platelet aggregation and multiple sclerosisActa Neurologica Scandinavica, 2009
- Aspirin as an Antithrombotic MedicationNew England Journal of Medicine, 1983
- Influence of Human Allergic Encephalitogenic Peptide on Platelet Aggregation in Multiple SclerosisEuropean Neurology, 1983
- Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitroBiochemical and Biophysical Research Communications, 1982
- Time and temperature dependent changes of ADP- and collagen-induced and “spontaneous” aggregationThrombosis Research, 1980
- Criteria for the clinical diagnosis of multiple sclerosisNeurology, 1976
- THE SYNTHESIS OF PROSTAGLANDINS IN PLATELETS FROM PATIENTS WITH MULTIPLE SCLEROSISActa Neurologica Scandinavica, 1975
- Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1970